- Home
- SPTN vs PLRX Comparison
SPTN vs PLRX Comparison
Compare SPTN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- PLRX
- Stock Information
- Founded
- SPTN 1917
- PLRX 2015
- Country
- SPTN United States
- PLRX United States
- Employees
- SPTN 17000
- PLRX N/A
- Industry
- SPTN Food Distributors
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- PLRX Health Care
- Exchange
- SPTN Nasdaq
- PLRX Nasdaq
- Market Cap
- SPTN 630.9M
- PLRX 680.3M
- IPO Year
- SPTN N/A
- PLRX 2020
- Fundamental
- Price
- SPTN $18.69
- PLRX $11.61
- Analyst Decision
- SPTN Hold
- PLRX Strong Buy
- Analyst Count
- SPTN 1
- PLRX 7
- Target Price
- SPTN $20.00
- PLRX $40.50
- AVG Volume (30 Days)
- SPTN 248.1K
- PLRX 485.5K
- Earning Date
- SPTN 02-12-2025
- PLRX 02-26-2025
- Dividend Yield
- SPTN 4.71%
- PLRX N/A
- EPS Growth
- SPTN 9.92
- PLRX N/A
- EPS
- SPTN 1.33
- PLRX N/A
- Revenue
- SPTN $9,532,883,000.00
- PLRX N/A
- Revenue This Year
- SPTN N/A
- PLRX N/A
- Revenue Next Year
- SPTN $2.15
- PLRX N/A
- P/E Ratio
- SPTN $14.06
- PLRX N/A
- Revenue Growth
- SPTN N/A
- PLRX N/A
- 52 Week Low
- SPTN $17.30
- PLRX $10.22
- 52 Week High
- SPTN $23.00
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- SPTN 56.59
- PLRX 47.63
- Support Level
- SPTN $17.77
- PLRX $10.35
- Resistance Level
- SPTN $18.66
- PLRX $11.07
- Average True Range (ATR)
- SPTN 0.40
- PLRX 0.55
- MACD
- SPTN 0.11
- PLRX 0.11
- Stochastic Oscillator
- SPTN 96.19
- PLRX 55.75
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.